Real SOTYKTU® patient, Emily, shares her story with SOTYKTU®, an oral medication for moderate to severe plaque psoriasis.

Ready to treat your moderate to severe plaque psoriasis from the inside?
CLEARER SKIN for nearly TWICE AS MANY PEOPLE vs Otezla® (apremilast), at 24 weeks† |
RESULTS THAT CAN LAST |
Just ONE PILL, taken once a day |
SOTYKTU was studied among 1684 adults in two large clinical trials. 841 received SOTYKTU, 422 received Otezla® (apremilast), and 421 received placebo (a pill with no medicine). Patients were assessed at 16, 24, and 52 weeks.
* | In one study, clear or almost clear skin was seen by 50% of people taking SOTYKTU vs 9% taking placebo at 16 weeks. In the same study, 90% clearer skin was seen by 32% of people taking SOTYKTU vs 20% taking Otezla at 24 weeks. |
† | In a second study, 90% clearer skin was seen by 42% of people taking SOTYKTU vs 22% taking Otezla at 24 weeks. |
‡ | In a follow-up study at 1 year and thereafter, 485 patients received continuous SOTYKTU through 5 years. 72% of people taking SOTYKTU saw 75% clearer skin at 1 year. 67% of people taking SOTYKTU saw 75% clearer skin at 5 years. Patients and physicians were aware of SOTYKTU treatment, which may have influenced their results. |
Looking for clearer skin?* See how SOTYKTU performed in clinical trials.
If you think it’s time for a change, ask your dermatology specialist these questions.
SO
HERE'S A QUESTION...